Transgene Biotek Ltd

Transgene Biotek Ltd

Transgene Biotek Ltd has informed that Regulation 57 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the company as there are no non-convertible securities with interest/dividend/principal payable during the quarter ended 30.06.2026.

Transgene Biotek Ltd

Transgene Biotek Ltd has submitted a statement of deviation and variation for the quarter ended June 30, 2026, stating that no public issue, rights issue, or preferential issue occurred during the period, making the submission of the statement not applicable.

Transgene Biotek Ltd

Transgene Biotek Ltd has informed that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended June 30, 2026, as no non-convertible securities were issued.